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Abstract 
BENIGN BREAST LESIONS 
Hasnan J , Mutum SS, Ismail AM, Hasbullah AS 
Pathology Department 
School of Medical Sciences 
Universiti Sains Malaysia 
16150 Kubang Kerian, Kelantan 
Malaysia 
The diagnosis of breast lesions in histopathology relies heavily on the morphology of the 
epithelial cells. This study aim at looking on the immunohistological expression of well-known 
prognostic markers ofbreast carcinoma i.e. CEA, c-erbB-2 and Cathepsin D on the epithelial 
cells of benign breast lesions in tissue sections and fine needle aspiration smears. Being strongly 
positive in malignant breast lesions, it is expected that the markers will be less positive or totally 
negative in beni~ epithelial cells. 
91 cases of benign breast leSions composed of 46 cases of fibroadenoma, 18 cases of fibrocystic 
change, 10 ~ of sclerosing adenosis, 9 cases of epithelial hyperplasia, 7 cases of papilloma 
and 1 case of lactating adenoma were identified in tissue sections. CEA was positive in 11 of the 
cases (12%) and Cathepsin D was positive in 20 cases (22%). Complete ring of epimembranous 
cytoplasmic C-erb-B2 expression was absent in all the cases, therefore it is considered that all 
cases were negative for c .. erb-B2 expression. 13 cases (14%) comprising of9 fibroadenoma, 2 
fibrocystic change and 2 epithelial hyperplasia showed incomplete ring of epimembranous 
staining by c-erb-B2. 
It appeare4 that CEA and c-erbB-2 expression is low in benign breast lesion and the expression is 
specific in the epithelial cells. However, CEA at the same time also showed strong positivity to 
the adjacent myoepithelial cells and this may give a higher result of positivity in such cases. For 
Cathepsin D expression, on top of showing strong positivity for myoepithelial cells and epithelial 
cells, it showed a non-specific positivity in the surrounding stromal cells. These findings indicate 
that c-erbB .. 2 and CEA rather than Cathepsin D are more likely to give a better distinguishing 
expression when comparing benign and malignant breast lesion in tissue sections. 
In 46 cases of fibroadenoma studied, CEA was positive in 10 cases (21. 7%) and Cathepsin Din 9 
cases (19.6%). In 18 cases offibrocystic change studied, none showed expression for CEA and c-
erbB-2 ; and 3 cases were positive for Cathepsin D. The same pattern is observed in sclerosing 
adenosis and papilloma cases studied. CEA and c .. erbB-2 were not expressed in 10 cases of 
sclerosing adenosis and 7 cases of papilloma. Cathepsin D was positive in 3 cases of sclerosing 
adenosis and 2 cases of papilloma 
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.. · Sl.cases of fine needle aspirates of benign breast lesion were also studied. 28·c~ compnsitig of 
21 fibroadenoma, 4 benign proliferative lesion, 2 fibrocystic change and 1 non-specific · 
inflammatory lesion were subjected to CEA staining while another 23 cases ·comprising .of 18 
. fibroadenoma, 3 beriign proliferative lesion, 1 :fibrocystic change and 1 non-specific 
inflammatory lesion were subjected to c-erbB-2 staining. For the CEA staining, 6· cases (21%) 
comprising of 5 fibroadenoma and 1 :fibrocystic change were positive. C-erbB-2 expression is 
only seen in one case ( 4%) out of 23 cases subjected to the staining and that single case was a 
fibroadenoma In the study of the fine needle aspirate, c-erbB-2 appears to be less expressed 
compare to CEA. · 
In conclusion, it can be seen that c-erbB-2 marker is significantly less expressed or not expressed 
at all compare to CEA in both tissue sections as well as in fine needle aspiration smears. 
Therefore c-erbB-2 marker is a potential tool that can be used to differentiate benign from 
malignant breast lesions. Cathepsin D due to its non-specific staining and increased background 
staining m.ake it unsuitable for usage to distinguish benign :from malignant breast lesions. 
Key words : CEA, c-erbB-2, Cathepsin D and benign breast lesions 
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Introduction 
Lump in the bre~ can be benign or malignant_ ~-~.!1!~-llJ!D.P _will be amendable to 
localized surgery Qr lumpect~my and has a good prognosis. However a malignant lump· 
may require removal of the breast tissue as well as the axillary tail of the breast. A 
malignant breast lesion may metastasize to other part of the body such as· the 'lungs and 
bone and this will have a very unfavowable outcome to the p~ent. Therefore, for a 
proper and appropriate treatment approach offer to the patient, the surgeon requires the 
help of the pathologist to make the correct diagnosis. 
There are two available methods of tissue biopsy that can be done to ascertain whether 
the breast lump is benign or malignant. These are tissue core biopsy and fine needle 
aspiration biopsy. 
.. 
-.... __ ..... ·- ~- - - . . -~ --· .. _,._ .. --- -----·· --· .--. - . 
Tissue core biopsy needs to be done under anaesthesia and the biopsy specimen will be 
fixed in 10% fonnalin before it undergoes tissue processing. The tissue will then be 
subjected to a series of chemicals and lat~r will be embedded in a paraffin wax. The end 
result is a tissue block. This tissue block will be cut into tissue section using a microtome 
and stained with Haematoxylin and eosin stain. The tissue section will be examined under 
the microscope by the pathologist and by analyzing the tumour cell morphology as well 
as the cell's interaction with the surrounding tissue an appropriate diagnosis will be 
offered. 
:r .• 
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On thr hand, fine needle b~opsy can ~~ooiie as ·aii .. oli1:iiitient1)rocedure. It reqUires the 
insertion of a 23 gauge needle into. th~ -~r~t lump ~~ the tissue 1\laterial is aspirated 
under vacu~ creat~~ in the attached syringe. The specimen is then spread onto glass 
slides and immediately fixed in 95% alcohol solution as well as air·dried. The ·atcohol : 
fixed smear will be stained with Papaniculaou stain while the air-dried smear is stained 
with May Grunwald Giemsa stain. The pap stain smear allow the pathologist to analyse 
the nuclear features of the tumour cells while the MGG stain will be able to highlight the 
cytoplasmic details of the cells. However, the pathologist will not be able to relate the 
cells morphology with the surrounding tissue as in core biopsy specimen as the smear 
does not show the tissue architecture of the tumour. 
In almost 90% of cases, an appropriate diagnosis can be reached. However, sometimes it 
. - ' 
is difficult to differentiate and distingui~h a benign from a malignant lesion. This occur 
when either the benign lesion show a bizaire cell morphology or tissue reaction that 
mimics a malignant lesion; or a malignant lesion showing a bland cell morphology or 
well differentiated glands that mimics a benign lesion instead. These situations require a 
great patient and experience on the part of the pathologist to interpret the biopsy. 
Benign versus malignant lesion 
Benign lesions of the breast include fibroadenoma and fibrocystic change. The diagnosis 
I of these lesion are straight forward most of the time. They occur mainly in young women 
I 
in the reproductive age group. Fibroadenoma presents as a firm discreet mobile painless 
' lump. Histologically, there is proliferation of the benign breast glands and also the 
· .. ' 
I' 
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. -~.: -~ :~):: . ..:"·~:.::.- .. : 
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prominent. Fibrocy~i-~_change m~~ pres~!!_t as a y~gu_~ painless lump in the breast and it 
. shows fibrosis, glands proliferation some of which are cystically dilated and hlso 
apocrine metaplasia. The presence of epithelial hyperplasia of the lining cells of the 
glands increases the risk of developing carcinoma in later years. When stromal fibrosis is 
prominent with many of the proliferating glands being compressed another benign lesion 
called sclerosing adenosis occurs. Sclerosing adenosis have bizarre tissue architecture 
that it may mimic the infiltrating nature of malignant breast lesion namely infiltrating 
ductal carcinoma. Benign lesion occurring in the lactiferous duct such as ductal 
papilloma may sometimes be difficult to differentiate from papillary carcinoma of the 
breast. 
Apart from looking at cells morphology of the tumour and its pattern of interaction of the 
surrounding tissue, one important feature of malignancy that need to observe is the 
breakage of the basement membrane and invasion of the tumour cells into the 
surrounding stroma. This is done for it patiently and diligently and also by highlighting 
the basement membrane using special stain s~ch as PAS stain or immunostain for 
laminin. 
CEA, c-erb-B2 and Cathepsin D 
CEA, c-erb-B2 and Cathepsin D are tumour markers that are found to be highly 
expressed in malignant breast tumour. In addition c-erb-B2 is strongly expressed in 
malignant cells that have the capacity to metastasize while Cathepsin D in invading cells. 
~ / ., 
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Cathepsin Dis a lysosomal enzyme involved in intracellular protein turnover in all cells. 
It is synthesized as a 54kD precursor and normally secreted in its mature and active form 
of approximately 46kD. In breast cancers, the Cathepsin antibody showed granular 
staining of variable intensity and occasionally stained the surrounding stromal tissues. 
Stained fibroblasts and macrophages provide built-in positive controls. Rarely, nuclei of 
some cancer cells were also stained. 
Objectives 
We aim to study the expression of breast tumour markers that have been shown to have a 
strong correlation with malignancy, invasion and metastasis which include CEA, c-
erbB-2 and Cathepsin D on benign breast lesions. The study will be conducted with a 
hypothesis that these markers should be expressed nil or low in the benign lesions. 
Studies that have been done so far on the expression of CEA and c-erbB-2 on benign 
lesions showed conflicting results. There was no study done on the expression of 
Cathepsin D on benign breast lesions. 
We hope to identify a reliable marker that will consistently be able to differentiate benign 
breast lesion from a malignant one directly, without having to go through tediously 
searching for evidence of tumour cells breaching their basement membrane. 
Materials and method 
A total of91 histopathology cases and 51 fine needle cases ofbenign breast lesions were 
identified from the registry book at the Pathology Laboratory, School of Medical 
Sciences, USM Kelantan. 
The histopathology cases came from either tissue biopsy or lumpectomy specimens. The 
fine needle cases were selected from archive materials that have more than one 
satisfactory smear. For all these cases, the patient data was recorded, the report and 
histology slides or fine needle smears were reviewed. 
The tissue blocks were retrieved and cut. The tissue sections produced were subjected to 
the standard three-stage immunoperoxidase staining- ABC (Complex Avidin-Biotin) 
method using the primary antibody CEA (Dako A 0 115), c-erb-B2 (Dako A 0485) and 
Cathepsin D (Dako A 0561 ). Antigen retrieval methods with microwave treatment were 
used. Sections were immersed in citrate buffer (pH 6.0) and heated in the microwave 
oven ( 600 watt) until boiling for 20 minutes. 
The fine needle slides selected for the study were de-stained and re-stained using the 
above staining method. Examination of the slides were done using light microscope at 
high magnification of 400X. 
The expression of the tumour was scored either positive or negative according to the 
following scoring scheme. 
For CEA and Cathepsin D expression, the presence of granular brown deposits in the 
cytoplasm of the epithelial mammary cells is considered as positive. 
For c-erb-B2 expression, cytoplasmic granular deposit AND complete ring of 
circumferential epimembranous staining is considered positive. An incomplete ring of 
epimembranous staining .or no epimembranous staining at all are considered negative. 
For the sake of quantitative analysis, the percentage of positive staining by all tumour 
markers and incomplete circumferential staining for c-erb-B2 is also counted by 
observing 100 ductal epithelial cells in the tissue sections. 
Results 
Of the 91 cases of~enign brea~t lesions diagnosed from trucut biospy and lumpectomy- ---------· _: ___ -
specime:n; 46 fibroadenoma, 18 fibrocystic change, 10 sClerosing adenosis~ 9 epithelial 
hyperplasia, 7 papilloma and !lactating adenoma were identified CEA was positive in 11 
of the 91 cases (12 %) and Cathepsin D was positive in 20 cases (22 %). C-erb .. B2 was not 
positive in any of the benign lesions. However~ 13 cases (14 %) of these cases showed incomplete 
ring of epimembranous staining. 
In 46 cases of fibroadenoma studietL CEA is positive in I 0 cases (21. 7%) and Cathepsin D is 
positive in 9 cases (19.6%). AlliS cases offibrocystic change studied showed no expression for 
CEA and c:..erbB .. 2; and only 3 cases were positive for Cathepsin D. The same pattern is observed 
in sclerosing adenosis and papilloma cases studied. CEA and c-erbB-2 were not expressed in 10 
cases of sclerosing adenosis and 7 cases of papilloma Cathepsin D was positive in 3 cases of 
sclerosing adenosis and 2 cases of papilloma 7 cases comprising of 5 fibroadenoma and 2 
fibrocystic change showed apocrine metaplasia. In the metaplastic cells, 3 out of 7 cases (42.8%) 
were positive for CEA, 1 case (14.3%) was positive for c-erb-B2 and all7 cases were positive for 
cathepsin D. 
A total of 51 cases of fine needle aspirates ofbenign breast lesion were also studied. 28 cases 
comprising of 21 fibroadenoma, 4 benign proliferative lesion, 2 fibrocystic change and 1 non-
specific inflammatory lesion were subjected to CEA staining while another 23 cases comprising 
of 18 fibroadenoma, 3 ·benign proliferative lesion, 1 :fibrocystic change and 1 non-specific 
inflammatory lesion were subjected to c-erbB-2 staining. For the CEA staining, 6 cases (21%) 
comprising of 5 fibroadenoma and 1 fibrocystic change were positive. C-..erbB-2 expression is 
only seen in one case ( 4%) out of23 cases subjected to the staining and that single case was a 
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fibroadeno~ In the study of the fine needle aspirate, c-erbB-2 appears to be less expressed 
compare to CEA. 
Table 1 :Positive expression ofCEA, c-erb-B2 and Cathepsin Din tissue sections of 91 cases of 
benign breast lesion 
Diagnosis N CEA C-erb-B2 CathepsinD 
Complete Incomplete 
Fibroadenoma 46 10 0 9 9 
Fibrocystic change 18 0 0 2 3 
Sclerosing adenosis 10 0 0 0 3 
Epithelial hyperplasia 9 1 0 2 2 
Papilloma 7 0 0 0 2 
Lactating adenoma 1 0 0 0 1 
Total 91 11 0 13 20 
Table 2 : Positive expression in fine needle aspiration smears of28 cases of benign breast lesion 
Diagnosis No. ofcases Positive CEA 
Fibroadenoma 21 5 
Fibrocystic change 2 1 
Benign Proliferative Lesion 4 0 
Inflammatory Lesion 1 0 
Total 28 6 
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Diagnosis No. of cases Positive c-erb-B2 
Fibroadenoma 18 1 
Fibrocystic change 1 0 
Benign proliferative lesion 3 0 
Inflammatory lesion 1 0 
Total 23 1 
Discussion 
Distinguishing benign from malignant brea,st lesions is an.lniportant challenge for a 
pathologist. While cell morphology, pattern of organization and surrounding tissue 
reations help to achieve this task moSt of the time, occasion does arise where the 
distinction is not clear cut. The breakage and invasion of the basement membrane by 
epithelial cells is the only true evidence of malignancy. Pathologist used to apply PAS 
stain to visualise the basement membrane but sometimes this can be difficult to interpret. 
A few researchers have gone identifying basement membrane markers such as type IV 
collagen, heparan sulphate proteoglycan and fibroneotin to assist pathologist in 
identifying malignant cells.(Birembaut et all985; Raymond WA and Leong AS 1991). 
Researchers have also suggested the use of staining for laminin and smooth muscle actin 
to identify the basement membrane and myoepithelial cells.( Liotta LA et al1984; 
Tsubura A et al, 1988; Raymond WA and Leong AS 1991; Guelstein VIet all993). This 
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h~ help a lot f~r ~e pa~Iogist. However, thes~ markers cannot be appiied to· fine 
needle aspirati'?~ spec~~~ns as the tissue ~~mte.Gture and basement membrane are absent. 
The tumour markers ofCEA, c-erb-B2 and Cathepsin had been shown in. various studies -
to correlate .well with breast carcinoma aggressiveness. 
Duffy et all983 reported the presence of CEA-like material in 51 out of 62 primary 
human breast carcinomas and in only 2 out of 12 fibroadenomas. CEA expression is also 
low in preneoplastic in-situ carcinoma according to Matsuk:u.ma A et al. 
However, Bhatavdekar JM et al 1987 while studying preoperatively plasma CEA 
concentration in 128 patients with breast cancer and Robertson et al 1989 studying the 
expression of CEA in 180 primary breast cancer showed no significant correlation 
between CEA and prognosis of the disease studied. 
In a study done by Nap Metal (1984) to see the expression of CEA and NCA on 52 
benign and 92 malignant lesions of the breast, they found out that CEA was positive in 
42% of cases of malignancy and totally negative in fibroscystic disease and 
fibroadenomas. This result differs from our study that showed CEA being positive in 
21.7% of fibroadenomas even though the fibrocystic disease cases also were totally 
negative as theirs. They suggested that CEA is cancer specific in breast lesions but our 
findings did not support that. Another important feature of CEA expression on benign 
lesions was the fact that myoepithelial cells also expressed the marker and this will make 
interpretation difficult and may give rise to false positive cases . 
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Papotti Metal (1983) repo~ed that.CEA was positive in 85% ofpapillary carcfuonia and · ~ 
not expressed in papillo~a. Our study on 7 cases of papilloma also had shown negative · ·· - -
expression of CEA. In this regard, we agree with Papotti Met al that CEA can be used as 
a reliable marker to differentiate papilloma from papillary carcinoma of the breast. Our 
study on 28 cases of benign lesions in FNA smear showed that 6 cases stained positive 
for CEA. This indicates that CEA has a potential to differentiate benign fre>m malignant 
lesions in FNA breast smear. 
c ... erb-B2 protein expression had been found to be strongly correlated with prognosis of 
patient (Keshgegian AA and Cnaan A,l997; Fontana X et al1994; Tsuda H et al1990) 
and especially to nodal metastasis (Zhang GJ et al 1997). Metastatic potential of tumour 
cells which expressed c-er'Q .. B2 protein is high. Supanaranond K et a1 in 1997 studied the 
amplication of this gene in 90 benign breast lesions and 66 malignant cases. They found 
out that no gene amplification occur in the benign cases whj.le 28.8% of malignant cases 
! showed c-erb-B2 gene amplification and this was strongly correlated with positive nodal 
tnetastasis. 
Kalogeraki A et all996 studied expression of c-erb-B2 in FNA specimens of 20 breast 
carcinoma, 20 fibroadenomas and 20 atypical fibrocystic lesions and found expression of 
600.4>, 30% and 25% in the respective lesions. This finding on fibroadenoma differs from. 
our finding in 46 fibroadenomas that we studied which none of them showed positivity 
for the marker. c .. erb.B2 expression was negative in all 50 cases of fibrocystic disease 
studied by Goussia A et al 1995 and they stated that their results implied that benign 
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lesions ~re ilegap:":e ~or c .. erb-B2. These findings are supported by our study also. ~ 
. . ... 
Al~~ev BA et;al ~~~ ?O!~d that none of the 58_ cases ofbenign breast lesions studied 
stained with c-erbB-2 whi).e 48.06% of 129 sporadic breast carcinoma were positive . 
. McCann A et a1 studied 200 breast carcinoma and 46 benign lesions for c-erb-B2 
expression and found out that with exception of one case of apocrine metaplasia, none of 
the remaining benign breast samples (n=45) were positive for this oncoprotein. Our result 
showed similar finding where all the benign cases were negative for c-erbB-2 except for 
one case showing positivity in its apocrine metaplastic component. This fact indicates 
that c-erbB-2 expression has a powerful distinguishing power to differentiate benign from 
malignant cells in tissue sections. The other important beneficial staining quality of the c-
erbB-2 is the fact that it was not expressed by the myoepithelial cells and the stromal 
cells. This will greatly prevent false positive cases. 
Our study on 23 cases of FNA specimen ofbenign cases also implied that c-erbB-2 can 
be used in FNA material also for differentiating benign from malignant lesions. This is 
more specific (only 4% expression) compare to that of CEA expression of21% in benign 
FNA breast smear. 
Cathepsin D is an enzyme that appears to be markedly increased in malignant breast 
tumour and strongly associated with prognosis of breast carcinoma (Losch A. et al 1998; 
Joachim EE et al1998; Fwco RA et al 1998). l ccording to Garcia Metal, Cathepsin D 
appears to facilitate cell growth at distant sites rather than increase cancer cell escape 
. . 
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-fro~.P~ tum.o~ thro~gh_ basement membrane degraclation as proposed. for ne~tral · 
p~~tei~ases. This protein is e~ressed in the surrounding strotnal cells and a study done . _ 
by Nadji Metal suggested that the.Cathepsin D in strom& cells, but-not in tumour ~lis, 
is associated with aggressive behaviour in node-negative ductal carcinoma of the breast. 
To our knowledge, there is no study been done on Cathepsin D expression on benign 
breast lesions. In our study, Cathepsin D was expressed in 20 out of91 benign. breast 
lesions (22%) and its expression is seen in all type of benign cases studied This indicates 
that Cathepsin D is not suitable to be used to differentiate benign from malignant cases. 
Furthermore, we found out that the expression in the stromal cells add up to the difficulty 
in visualizing the reactivity in the epithelial cells and this is especially so in cases where 
there are prominent stromal reactions. At the same time, Cathepsin D also stained up the 
myoepithelial components of the benign lesions. The marker was also strongly expressed 
in apocine metaplasia and all our 7 cases of apocrine metaplasia stained strongly positive 
for Cathepsin D. 
In conclusion, we found that c-erbB-2 is a reliable marker that is totally absent in benign 
cases. It can be used in difficult cases such as differentiating sclerosing adenosis from 
infiltrating carcinoma or papilloma from papillary carcinoma. CEA can also be used in 
the same manner however it has a limitation where it stained myoepithelial cells and this 
will affect the results. We found that Cathepsin D expression is unsuitable for 
differentiating benign from malignant breast lesions due to background stromal cell 
staining reaction. We have not looked into the possibility of using these markers to 
differentiate preneoplastic lesions such as Ductal Carcinotna In Situ fro1n malignant 
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~esiol!S and the poteptiai or these markers can be·exptored in this aspect. Lastly, a larger ·. · :\· 
~dy with more ~~pies are required to validate our findings. . ________ . .. _ _ _______ .. 
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